MKI67 and non-small cell lung carcinoma: In general, Pirfenidone exerted an effect on cellular proliferation, as indicated by reduced Ki67 protein level and BrdU incorporation, as well as G0/G1 arrest in the cell cycle in five different NSCLC cell lines.